Your browser doesn't support javascript.
loading
Population pharmacokinetics and target attainment analysis of vancomycin after intermittent dosing in adults with cystic fibrosis.
Yellepeddi, Venkata K; Lindley, Bryn; Radetich, Emi; Kumar, Shaun; Bhakta, Zubin; Leclair, Laurie; Parrot, Madison; Young, David C.
  • Yellepeddi VK; Division of Clinical Pharmacology, Department of Pediatrics, Spencer Fox Eccles School of Medicine, University of Utah , Salt Lake City, Utah, USA.
  • Lindley B; Department of Molecular Pharmaceutics, College of Pharmacy, University of Utah , Salt Lake City, Utah, USA.
  • Radetich E; Department of Pharmacotherapy, College of Pharmacy, University of North Texas Health Science Center , Fort Worth, Texas, USA.
  • Kumar S; Adult Cystic Fibrosis Center, University of Utah Health , Salt Lake City, Utah, USA.
  • Bhakta Z; Department of Pharmacotherapy, College of Pharmacy, University of Utah , Salt Lake City, Utah, USA.
  • Leclair L; Parexel International , Sydney, Australia.
  • Parrot M; Adult Cystic Fibrosis Center, University of Utah Health , Salt Lake City, Utah, USA.
  • Young DC; Adult Cystic Fibrosis Center, University of Utah Health , Salt Lake City, Utah, USA.
Antimicrob Agents Chemother ; 68(1): e0099223, 2024 Jan 10.
Article en En | MEDLINE | ID: mdl-38059634
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrosis Quística / Staphylococcus aureus Resistente a Meticilina Límite: Adult / Humans Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrosis Quística / Staphylococcus aureus Resistente a Meticilina Límite: Adult / Humans Idioma: En Año: 2024 Tipo del documento: Article